Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trials symbols : Nvsef save search
Clinical trials market size in US to grow by USD 5.9 billion from 2022 to 2027, The rise in the number of clinical trials of drugs is the key factor driving market growth, Technavio
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
TMO | News | $544.01 0.46% 470K
|
Health Technology
|
| O: 0.64%
H: 1.7%
C: 0.54%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.2%
H: 0.71%
C: 0.33%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
ICLR | $288.625 -1.1% 73K
|
Health Technology
|
| O: 2.54%
H: 0.22%
C: -2.44%
trials key market
Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticaria
Published: 2023-08-09 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
urticaria rapid control trials novartis
Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
VTRS | $11.23 0.99% 1.5M
|
Health Technology
|
| O: 0.22%
H: 0.65%
C: -1.09%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: -2.04%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.66%
H: 0.18%
C: -0.9%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
CNTG | $0.461 14K
|
Commercial Services
|
| O: 1.23%
H: 27.27%
C: -15.76%
europe report dementia trials research growing market
Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III trials
Published: 2022-09-10 (Crawled : 08:20) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.815 1.35% 410K
|
Health Technology
| Email alert
Add to watchlist
cosentyx trials novartis
GlobalData Plc: North America Accounted for Highest Number of Social Anxiety Disorder Clinical Trials Conducted in 2022
Published: 2022-06-02 (Crawled : 16:00) - globenewswire.com
AZNCF | $138.24 800
|
Health Technology
|
| O: 0.97%
H: 0.19%
C: -3.52%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.73%
H: 0.12%
C: 0.1%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
AZN | $68.3 -0.09% 2M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
america trials social anxiety disorder
Non-alcoholic Steatohepatitis Clinical Trials Market Size Worth $4.2 Billion By 2030: Grand View Research, Inc.
Published: 2022-02-01 (Crawled : 11:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -1.59%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
ICLR | $288.625 -1.1% 73K
|
Health Technology
|
| O: 0.89%
H: 0.59%
C: 0.41%
hepatitis als trials research trial clinical trials
Global CAR-T Cell Therapy Markets to 2026: Rising Clinical Trials and Development of New and Effective Therapy Options
Published: 2021-09-28 (Crawled : 16:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.12%
H: 1.77%
C: -0.99%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.16%
H: 0.04%
C: -0.51%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.04%
H: 0.5%
C: -0.18%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: -0.09%
H: 0.93%
C: -0.26%
SGMO | $0.5225 7.71% 500K
|
Health Technology
|
| O: -1.12%
H: 0.52%
C: -2.17%
AUTL | $4.73 -1.46% 99K
|
Health Technology
|
| O: -2.67%
H: 1.27%
C: -5.48%
AMGN | $266.895 1.58% 950K
|
Health Technology
|
| O: -0.38%
H: 1.16%
C: -0.01%
clinical trials therapy car-t trials trial t-cell
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.